PG-033
PG-033-ND-101
Phase 1 small_molecule active
Quick answer
PG-033 for Lichen Simplex Chronicus is a Phase 1 program (small_molecule) at Prime Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Prime Medicine
- Indication
- Lichen Simplex Chronicus
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active